HSP-90 inhibitors promise to complement cancer therapies.
Vastag
Brian
B
D016227:Benzoquinones / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004345:Drug Industry; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D047029:Lactams, Macrocyclic / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy*
D016227:Benzoquinones; D004791:Enzyme Inhibitors; D018841:HSP90 Heat-Shock Proteins; D047029:Lactams, Macrocyclic; C001277:geldanamycin